THE EFFECTS OF MODAFINIL ON STRIATAL, PALLIDAL AND NIGRAL GABA AND GLUTAMATE RELEASE IN THE CONSCIOUS RAT - EVIDENCE FOR A PREFERENTIAL INHIBITION OF STRIATOPALLIDAL GABA TRANSMISSION
L. Ferraro et al., THE EFFECTS OF MODAFINIL ON STRIATAL, PALLIDAL AND NIGRAL GABA AND GLUTAMATE RELEASE IN THE CONSCIOUS RAT - EVIDENCE FOR A PREFERENTIAL INHIBITION OF STRIATOPALLIDAL GABA TRANSMISSION, Neuroscience letters, 253(2), 1998, pp. 135-138
The effects of the anti-narcoleptic drug modafinil (30-300 mg/kg i.p.)
on GABA and glutamate release were evaluated in the basal ganglia of
the conscious rat, by using the microdialysis technique. Modafinil (10
0 mg/kg) inhibited striatal (85 +/- 4% of basal values) and pallidal (
85 +/- 2%) GABA release without influencing local glutamate release. A
t the highest dose (300 mg/kg), modafinil induced a further reduction
of pallidal (75 +/- 2%) but not striatal (82 +/- 7%) GABA release and
increased striatal (134 +/- 11%) but not pallidal glutamate release. O
n the contrary, in the substantia nigra modafinil reduced GABA release
only at the 300 mg/kg dose (59 +/- 5%) without affecting glutamate re
lease. The preferential reduction in striato-pallidal GABA release at
the 100 mg/kg dose of modafinil suggests that modafinil may be useful
in the treatment of Parkinsonian diseases. (C) 1998 Published by Elsev
ier Science Ireland Ltd. All rights reserved.